Form 144 TECTONIC THERAPEUTIC For: 1 October
- Investing.com
- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Tectonic Therapeutic Inc (TECX)
The Tectonic Therapeutic share price today is 23.330, view NASDAQ TECX stock exchange data. Track the latest Tectonic Therapeutic share price with real-time updates on TECX stock performance including market cap, day range, 52-week range and dividend yield. Access TECX charts, earnings dates and analyst estimates to support your investment decisions.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
22.740
23.610
52 wk Range
15.450
39.528
TECX is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
22.74023.610
52 wk Range
15.45039.528
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
TECX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
76.625
Upside
+228.44%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in oversold territory
AVROBIO receives Investment Bank Analyst Rating Update- Investing.com
Pro
AVROBIO receives Investment Bank Analyst Rating Update- Investing.com
Pro
- Form 144 TECTONIC THERAPEUTIC For: 1 October
- Investing.com
- AVROBIO receives Investment Bank Analyst Rating Update
- Investing.com
Pro 
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Analyst Ratings
9 Buy
0 Hold
0 Sell
Ratings:
9 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 76.625
(+228.44% Upside)
Earnings
Latest Release
06-08-2026
EPS / Forecast
-1.18 / -1.35
Revenue / Forecast
-- / --
Compare TECX to Peers and Sector
Metrics to compare | TECX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipTECXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −5.3x | −6.1x | −0.3x | |
PEG Ratio | 0.40 | 0.26 | 0.00 | |
Price/Book | 2.0x | 2.3x | 2.6x | |
Price / LTM Sales | - | 26.6x | 3.0x | |
Upside (Analyst Target) | 228.4% | 91.0% | 61.2% | |
Fair Value Upside | Unlock | −3.4% | 7.2% | Unlock |
Tectonic Therapeutic, Inc., a biotechnology company, focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G protein coupled receptors (GPCRs). It develops GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines. The company’s lead product is TX45, a Fc-relaxin fusion molecule that activates the RXFP1 receptor, the GPCR target of the hormone, and relaxin. It is also developing TX2100 for the treatment of hereditary hemorrhagic telangiectasia; GPCR modulator bispecific for treating fibrosis; and other GPCR modulators. The company is headquartered in Watertown, Massachusetts.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Tectonic Therapeutic (TECX) Share Price Today?
The Tectonic Therapeutic share price today is 23.330.
What is the current Tectonic Therapeutic (TECX) share price and day range?
As of 11-10-2026, the Tectonic Therapeutic share price is 23.330, with a previous close of 23.330. The share price has ranged from 22.740 to 23.610 today, while the 52-week range spans from 15.450 to 39.528.
What Is the Tectonic Therapeutic Market Cap?
As of today, Tectonic Therapeutic market cap is 456.090M.
What Is the Tectonic Therapeutic (TECX) Share Price Target?
The average 12-month share price target for Tectonic Therapeutic is 76.625, with a high estimate of 93 and a low estimate of 60. 9 analysts recommend buying, while 0 suggest selling, with an overall rating of Strong Buy and +228.44% Upside potential.
What Is Tectonic Therapeutic's Earnings Per Share (TTM)?
The Tectonic Therapeutic EPS (TTM) is -4.565.
When Is the Next Tectonic Therapeutic Earnings Date?
Tectonic Therapeutic will release its next earnings report on 05-11-2026.
From a Technical Analysis Perspective, Is TECX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
What Stock Exchange Does Tectonic Therapeutic Trade On?
Tectonic Therapeutic is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Tectonic Therapeutic?
The stock symbol for Tectonic Therapeutic is "TECX."
How Many Times Has Tectonic Therapeutic Stock Split?
Tectonic Therapeutic has split 1 times.
How Many Employees Does Tectonic Therapeutic Have?
Tectonic Therapeutic has 60 employees.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.